Ventilatory response to CO2 during exercise remains profoundly low in patients with Congenital Central Hypoventilation Syndrome, with no significant difference from resting values.
In 10 patients with CCHS, the ventilatory response to CO2 during exercise was 2.27 mL/min/mmHg/kg, which was not significantly different from the resting value of 1.56 mL/min/mmHg/kg (p=0.85). Both values were markedly lower than the reference value in healthy children (34.6 mL/min/mmHg/kg), indicating persistent impairment of CO2-driven ventilatory control despite increased metabolic demand.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Ventilatory response to CO2 during exercise remains profoundly low in patients with Congenital Central Hypoventilation Syndrome, with no significant difference from resting values. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Ventilatory response to CO2 during exercise remains profoundly low in patients with Congenital Central Hypoventilation Syndrome, with no significant difference from resting values.
This conclusion is most relevant to: 10 patients with genetically confirmed Congenital Central Hypoventilation Syndrome (CCHS), median age 13.5 years (IQR 12.3-15.5)..
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Ventilatory Response to CO2 During Exercise in Patients With Congenital Central Hypoventilation Syndrome. (Pediatric pulmonology, 2026) —
How It Works
The proposed biological pathway:
- ▸Central chemoreceptor dysfunction in CCHS impairs detection of CO2 changes
- ▸During exercise, metabolic demand increases CO2 production
- ▸Normal compensatory increase in ventilation fails to occur
- ▸Result: Persistent hypoventilation with elevated EtCO2 and decreased SpO2 during exercise
Who Might Benefit
Evidence fit by population:
- ▸10 patients with genetically confirmed Congenital Central Hypoventilation Syndrome (CCHS), median age 13.5 years (IQR 12.3-15.5).
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Small sample size (n=10) limits generalizability
- ▸No direct comparison with healthy control group; reference values from literature used
Frequently Asked Questions
What is Congenital Central Hypoventilation Syndrome (CCHS)?▼
CCHS is a rare genetic disorder characterized by a markedly impaired ventilatory response to CO2 due to central chemoreceptor dysfunction, leading to inadequate breathing, especially during sleep and exercise.
How was ventilatory response measured in this study?▼
Ventilatory response to CO2 (VRCO2) was calculated as the change in minute volume divided by the change in end-tidal CO2, normalized by body weight (mL/min/mmHg/kg), during a treadmill exercise test and at rest using the CO2 rebreathing method.
Did patients with CCHS experience any symptoms during exercise?▼
No patients reported dyspnea, and no serious adverse events occurred during the exercise test, despite objective evidence of hypoventilation.
What is the clinical implication of this study?▼
The findings underscore the importance of objective physiological assessment (e.g., CPET) rather than relying on subjective symptoms to guide exercise recommendations in CCHS patients.
References
- 1.Ikeda K, Hasegawa H, Yamada Y, Wasa M, Kanabuchi S. “Ventilatory Response to CO2 During Exercise in Patients With Congenital Central Hypoventilation Syndrome..” Pediatric pulmonology, 2026. PMID: 42530439 DOI: 10.1002/ppul.71767